Review articlePublished 29 Mar 2023
Ayurveda Treatment of Brahmi Vati in Generalized Anxiety Disorder
Department of oncology, MRC Research Centre, University of Cambridge, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Generalized Anxiety Disorder (GAD) is the foremost common anxiety disorder. GAD has tall comorbidities and it can influence social, proficient and individual life. Ayurvedic medicine, Brahmi vati is investigated for the possible role in management of GAD and is compared to Manasmitra vataka. A randomized double blind controlled trial, with total 56 patients meeting the DSM V criteria of GAD between 20–60 years of age and either sex participated within the study. Members were randomly partitioned into two groups, Brahmi group received capsule B. vati 500 mg and Manasmitra group received capsule M. vataka 500 mg thrice a day with water for 45 days. Assessments were conducted through different clinical parameters such as Hamilton Anxiety Rating Scale. Blood variables including Hemoglobin, Erythrocyte Sedimentation Rate (ESR), Liver Function Test (LFT) and serum creatinine were assessed before and after the study. Evaluations amid intervention were conducted on every 15th day. B. vati and M. vataka were effective, secure and comparable within the management of GAD.
Subjects
Alternative & Palliative CareAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Traditional Medicine & Clinical Naturopathy
- SubjectAlternative & Palliative Care
- BylineArticles whose byline prints “Helen Davies”